Boehringer Ingelheim launches three phase III trials in precision Oncology
Boehringer Ingelheim has initiated three Phase III clinical trials aimed at advancing…
Burjeel Cancer Institute Honors 15 Cancer Survivors at ‘Circle of Hope’ Event
Burjeel Cancer Institute honored 15 cancer survivors during its ‘Circle of Hope’…
UAE Approves New Oral Breast Cancer Treatment for Hormone-Resistant Cases
The UAE has approved AstraZeneca’s Etcamah, a new oral therapy for advanced…
LCRF and AstraZeneca Launch Research Awards to Advance Small Cell Lung Cancer Treatment
The Lung Cancer Research Foundation (LCRF), in collaboration with AstraZeneca, has announced…
IBA Announces Research Collaboration to Strengthen Evidence on the Value of Proton Therapy
IBA has entered into a sponsored research agreement with The University of…
Harbour BioMed Announces NMPA Acceptance for the Treatment of Advanced Solid Tumors
Harbour BioMed has announced that China’s National Medical Products Administration (NMPA) has…
Theromics Appoints Andrew C. Zeringue as Chief Executive Officer
Theromics Inc. has appointed Andrew C. Zeringue as Chief Executive Officer, bringing…
ImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory to Expand BCG Supply in the United States
ImmunityBio has signed an exclusive U.S. development and supply agreement with Japan…
Rigel Pharmaceuticals Signs Global Licensing Deal for VEPPANU™ Breast Cancer Treatment
Rigel Pharmaceuticals has entered an exclusive global licensing agreement with Arvinas and…
Dr. Soliman Fakeeh Hospital launches Madinah’s first advanced radiation therapy center
Dr. Soliman Fakeeh Hospital has launched Madinah’s first advanced radiation therapy center,…
